Synthetic CBD Alternatives Show Less Toxicity and Protect Brain Cells from Alcohol Damage
Two synthetic CBD analogues (PQM-242 and PQM-249) were over 13 times less toxic to brain cells than natural CBD while maintaining similar protective effects against alcohol-induced cell death.
Quick Facts
What This Study Found
Synthetic CBD analogues PQM-242 and PQM-249 showed LC50 values >600 µM compared to CBD's 44 µM (>13x less toxic), with NOAELs of 100 µM vs. CBD's 10 µM, while still protecting against ethanol-induced apoptosis in neuronal cells.
Key Numbers
CBD LC50: 44 µM; PQM-242 and PQM-249 LC50: >600 µM; CBD NOAEL: 10 µM; analogue NOAEL: 100 µM; ethanol challenge at 250 mM; PQM-242 additionally prevented Bax upregulation.
How They Did This
In vitro study comparing natural CBD with two synthetic derivatives in human SH-SY5Y neuroblastoma cells, assessing cytotoxicity (MTT), apoptosis (annexin V/PI), and Bax/Bcl-2 expression after 48-hour exposure and ethanol challenge.
Why This Research Matters
CBD shows promise for alcohol use disorder but has a narrower safety window than assumed — these synthetic alternatives could provide the same benefits with a much wider margin of safety.
The Bigger Picture
If these synthetic analogues maintain their safety advantage in animal and human studies, they could become preferred therapeutics for alcohol use disorder — addressing a condition with limited pharmacological options.
What This Study Doesn't Tell Us
In vitro neuroblastoma cell line; ethanol concentration (250 mM) is supraphysiological; does not address in vivo pharmacokinetics or behavioral outcomes.
Questions This Raises
- ?Will the improved safety profile of PQM-242/PQM-249 translate to in vivo models?
- ?Can these analogues cross the blood-brain barrier effectively?
Trust & Context
- Key Stat:
- Evidence Grade:
- In vitro study with clear dose-response data and mechanistic analysis, but very early-stage findings requiring in vivo validation.
- Study Age:
- Published in 2026, representing cutting-edge synthetic cannabinoid analogue development.
- Original Title:
- Synthetic cannabidiol analogues exhibit lower toxicity than cannabidiol and protect against ethanol-induced apoptosis in SH-SY5Y cells.
- Published In:
- Neurotoxicology, 113, 103411 (2026)
- Authors:
- Almeida, Carolina Aparecida Faria, Salles, Gabriela, Bruno, Vitor, Ribeiro, Jessyca Milene, Silva, Alessandra Oliveira, de Assis Braz, Giulia, Castelhano, Felype Valentim Duarte, Dos Reis Rosa Franco, Graziella, Viegas, Cláudio, Marcourakis, Tania, Torres, Larissa Helena Lobo, Garcia, Raphael Caio Tamborelli
- Database ID:
- RTHC-08074
Evidence Hierarchy
Frequently Asked Questions
Are there safer alternatives to CBD?
This study found two synthetic CBD analogues (PQM-242 and PQM-249) that were over 13 times less toxic to brain cells than natural CBD while maintaining similar protective properties — though these are still in early research stages.
Can CBD help with alcohol addiction?
CBD shows therapeutic potential for alcohol use disorder, but this study highlights that natural CBD has a narrower safety margin than often assumed. Synthetic analogues may offer improved safety profiles for this application.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-08074APA
Almeida, Carolina Aparecida Faria; Salles, Gabriela; Bruno, Vitor; Ribeiro, Jessyca Milene; Silva, Alessandra Oliveira; de Assis Braz, Giulia; Castelhano, Felype Valentim Duarte; Dos Reis Rosa Franco, Graziella; Viegas, Cláudio; Marcourakis, Tania; Torres, Larissa Helena Lobo; Garcia, Raphael Caio Tamborelli. (2026). Synthetic cannabidiol analogues exhibit lower toxicity than cannabidiol and protect against ethanol-induced apoptosis in SH-SY5Y cells.. Neurotoxicology, 113, 103411. https://doi.org/10.1016/j.neuro.2026.103411
MLA
Almeida, Carolina Aparecida Faria, et al. "Synthetic cannabidiol analogues exhibit lower toxicity than cannabidiol and protect against ethanol-induced apoptosis in SH-SY5Y cells.." Neurotoxicology, 2026. https://doi.org/10.1016/j.neuro.2026.103411
RethinkTHC
RethinkTHC Research Database. "Synthetic cannabidiol analogues exhibit lower toxicity than ..." RTHC-08074. Retrieved from https://rethinkthc.com/research/almeida-2026-synthetic-cannabidiol-analogues-exhibit
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.